FDA clears Camber Spine Technologies’ Siconus SI Joint Fixation System: 4 points

Wayne, Pa.-based Camber Spine Technologies received FDA clearance for its Siconus SI Joint Fixation System.

Advertisement

Here are four points:

 

1. The Siconous is Camber Spine Technologies’ second product for sacroiliac disease treatment, complementing the company’s Prolix system.

 

2. The Siconous is designed to offer fixation and stabilization of large bones as an adjunct to SI joint fusion.

 

3. In combination with the Prolix, the Siconous provides “direct visualization and insertion of a machined allograft spacer into the SI joint, followed by a lateral approach compression and fixation implants,” explained Daniel Pontecorvo, founder and CEO of Camber Spine Technologies.

 

4. A collaborative agreement between Camber Spine Technologies and the Institute for Musculoskeletal Science & Education allowed the Siconous system to come to fruition.

 

More articles on devices:
Why 2017 is a big year for minimally invasive spine surgery: Q&A with Paradigm Spine Chairman & CEO Marc Viscogliosi
Global orthopedic devices market to grow at 5% CAGR through 2022 — 3 observations
Zimmer Biomet, Implanet, Spinal Elements & more: 8 device company key notes

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.